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Hemoglobin (Hb) is the main carrier of oxygen. In general, high-end Hb levels within the normal range are considered beneficial for health 1 . However, activation of the hypoxia response has been shown to protect mice against metabolic dysfunction [2] [3] [4] . We used Hb levels as an indicator for oxygenation status and studied its association with >170 anthropometric or metabolic parameters in two Finnish birth cohorts (total n = 7,175) in a longitudinal design. Here we show a remarkable strong positive linear association between Hb levels and body mass index (BMI).
Subjects with the lower Hb levels also had better glucose tolerance, lower cholesterol and blood pressure levels, less adverse metabolite profiles and lower inflammatory load. Notably, these associations were not only mediated by the lower BMI, and the effect size of many of them increased with age. Polygenic risk score analyses indicated shared genetic determinants between
Hb levels and BMI and insulin, triglyceride and HDL cholesterol levels. Manipulation of Hb levels by venesection in mice confirmed causal effects on body weight and metabolic parameters.
Our findings suggest that lower-end normal Hb levels are favorable for and maintenance of healthy metabolism involving mild chronic activation of the hypoxia response. Therefore modulation of Hb levels could serve as a novel strategy towards treatment of metabolic syndrome. 4 Hb, an iron-containing metalloprotein in red blood cells, is the main carrier of oxygen. Its levels directly affect arterial oxygen concentration and thereby tissue oxygenation 5, 6 . Hb levels are regulated genetically and environmentally, and they vary by sex, race, age and altitude 1, 7 .
Individual's Hb levels during adult life are, however, very stable and used e.g. in the athlete's biological passport to detect doping 8 . When tissues encounter reduced oxygen levels as a key transcriptional response the hypoxia-inducible factor (HIF) becomes stabilized. It upregulates genes that induce oxygen delivery and reduce its usage, such as those regulating energy metabolism 9 . The stability of HIF is governed by HIF prolyl 4-hydroxylases (HIF-P4Hs), which require oxygen for catalysis and targeting HIF for destruction 9 . Recent studies show that inhibition of HIF-P4Hs, which stabilizes HIF in normoxia, protects mice from obesity, metabolic dysfunction and associated diseases 2-4, 10, 11 . To investigate oxygenation status with regards to metabolic health in human population at a larger scale, we explored the possibility to use the normal variation in Hb levels as a surrogate measure. To test this we first evaluated the association of Hb levels with key metabolic parameters in C57Bl/6 mice. We found positive associations between Hb levels and body weight, glucose tolerance and homeostatic model assessment-insulin resistance (HOMA-IR) scores, respectively (Figs. 1a-1c), suggesting that Hb levels can influence metabolic health.
We then examined association of Hb levels in humans with anthropometric and metabolic parameters in cross-sectional and longitudinal design from 31 to 46 years in the population based, sea-level Northern Finland Birth Cohort 1966 (NFBC1966) 12, 13 (n = 5,351), and searched for a replication in another sea-level cohort, Cardiovascular Risk in Young Finns Study (YFS) 14 (n = 1,824). The statistical analyses were adjusted for potential confounding factors, and as appropriate, for BMI (see Methods and Extended data Figure 1 and Table 2 ). The increase of 10 g/l in Hb corresponded to an increase of 3.5% in BMI (Fig. 1b , Extended data Tables 2 and 3 ). Hb levels also associated positively with waist circumference, hip circumference, waist-hip ratio, body fat percentage and visceral fat area and negatively with body muscle percentage (Fig. 1b , Extended data Tables 2 and 3 ). Thus the subjects with the lower Hb levels appeared less abdominally obese and having more muscle tissue. Hematocrit levels and red blood cell counts also showed positive associations with BMI (Extended data Fig. 2 and Table 4 ).
We next showed by associating Hb and fasting glucose and insulin levels, and the derived insulin resistance indexes (HOMA-IR, HOMA-B and Matsuda 15 ) from an oral glucose tolerance test that the subjects with lower Hb levels had better glucose tolerance and insulin sensitivity than those with higher Hb levels (Fig. 2a , Extended data Table 5 ). There was also evidence for positive association between Hb and levels of systolic and diastolic blood pressure, serum total cholesterol, LDL cholesterol, triglycerides and serum high sensitive C-reactive protein (CRP), respectively, and negative association between Hb and HDL cholesterol levels (Fig. 2a , Extended data Table 5 ). The effect sizes of these associations weakened when additionally adjusted for BMI, but all except that for CRP remained significant (Fig. 2a , Extended data Table 5 ).
To evaluate in a longitudinal set up the association of Hb levels with anthropometric and metabolic measures, we compared the effect sizes of these associations in subjects of NFBC1966 that had been examined for them at age of 31 and 46 years (n = 3,624). As expected, the mean Hb levels had stayed unchanged from 31 to 46 years (Extended data Figure 3 ). In general, the effect sizes of the associations increased with age or stayed the same (Fig. 2b) , the most pronounced increases being found for the association of Hb levels with levels of triglycerides and insulin, 6 HOMA-IR and waist-hip-ratio, respectively (Fig. 2c , Extended data Tables 6 and 7) .
We then evaluated the association between Hb levels and systemic metabolite profiles of 150 variables analyzed by nuclear magnetic resonance (NMR) metabolomics. Evidence for associations of Hb levels was found with lipoprotein subclass particle concentrations and particle sizes, and levels of ApoB, triglycerides and cholesterol in lipoproteins, fatty acids (FAs), lactate, glycerol, branched-chain amino acids isoleucine, leucine and valine, aromatic amino acids phenylalanine and tyrosine, the inflammatory glycoprotein acetyls, creatinine, albumin and ketone bodies, respectively, these associations being mostly positive (Fig. 3 , Extended data Table   8 ). High levels of branched-chain and aromatic amino acids, glycoprotein acetyls and lactate, associated with the higher Hb levels here (Fig. 3 , Extended data Figure 4) . Furthermore, the estimated slope for regression of longitudinal effects on cross-sectional effects (0.97, 95% CI 0.89 to 1.05) indicated similar effects sizes for both the between-subject and the within-subject effects (Extended data Figure 4 ).
Altogether, lower Hb levels associated with less adverse metabolite profiles.
We next analyzed in a subpopulation of NFBC1966 19 association of Hb levels with oxygen consumption at rest, and found evidence for positive association of it and for those of oxygen consumption and body fat percentage and Hb levels and body fat percentage, respectively ( After adjustment for confounding factors, we found evidence for geneset level transcriptional activation of hypoxia-induced genes in individuals in the lowest Hb quartile (Hb < 132 g/l)
compared to the highest quartile (Hb > 152 g/l) ( Figure 4b ).
To examine for causality of Hb levels on BMI or the key metabolic measures bidirectional MR analyses were carried out using the European ancestry summary statistics from genome-wide meta-analysis studies 7, 21 for these variables. Neither inverse variance weighting (IVW) nor MREgger regression method gave substantial evidence for causality on any parameter to either direction (Extended data Table 11 and Figures 5 and 6 ). However, in classical MR using the genome wide single nucleotide polymorphisms (SNP) the instrument is weak. We therefore secondly optimized the instrument and carried out polygenic risk score analyses that revealed evidence for shared genetic determinants between Hb and BMI and levels of insulin, triglycerides and HDL cholesterol. However, with the currently available data sets the direction of causation remained unclear and its untangling would almost certainly require a larger Hb genome wide association study material (Extended data Table 12 ). We therefore manipulated Hb levels in C57Bl/6 mice by venesection, and showed that in two weeks the induced erythropoiesis increased their Hb levels which associated with increased body weight, insulin resistance and cholesterol levels ( Fig. 4c , Extended data Figure 7 ).
While no association of Hb levels with overall metabolic health has been reported before, high Hb or hematocrit levels have earlier been associated in individual epidemiological studies 8 with increased insulin resistance, hypertension, hypercholesterolemia or hypertriglyceridemia [22] [23] [24] [25] . Although the underlying mechanisms have been poorly understood hyperviscosity or changes in plasma volume have been suggested as mediators of these associations. The HIF pathway was only discovered after these analyses. One of the key adjustments in the hypoxia response is to reprogram energy metabolism transcriptionally to less oxygen consuming while less ATP producing, more inefficient mode 9, 26 (Fig. 4d) . The data presented here suggest that the lower Hb levels activated the hypoxia response which mediated the beneficial effects on metabolic health.
Individuals being environmentally exposed to hypoxia by living at high altitude have been reported to have a lower fasting glycemia and better glucose tolerance compared to those at near sea level, and demographic studies associate living at high altitude with protection against obesity and diabetes 27, 28 . Further, clinical trials with HIF-P4H inhibitors for treatment of anemia and ischemia reported ≥20% reduced cholesterol levels in patients receiving these therapeutics 29, 30 .
While more mechanistic studies are needed, our data show that Hb levels contribute significantly to metabolic health, and that variation in Hb levels should be considered in clinical practice as potential indicator of risk of metabolic disadvantage.
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Blood analyses
Blood samples of NFBC1966 were taken after an overnight fasting period, centrifuged immediately and before analysing samples of 31-years were stored firstly at −20 °C and later at −80 °C, whereas samples of 46-years were analysed immediately without storing. NFBC1966 blood samples were analysed in NordLab Oulu (former name Oulu University Hospital, Laboratory), a testing laboratory (T113) accredited by Finnish Accreditation Service (FINAS) (EN ISO 15189). For YFS blood analyses, see 3 .
Blood haemoglobin (Hb) level and red blood cell parameters
Blood Hb and red cell parameters of NFBC1966 were determined using a Coulter STKR analyser (Beckman Coulter, Fullerton, CA, USA) at age 31-years and a Sysmex XE-2100 analyser (Sysmex Corporation, Kobe, Japan) at age 46-year. The whole blood Hb levels of NFBC1966 were determined using spectrophotometric methods, red blood cells (RBC) were measured using electric resistance detecting methods (impedance technology) with hydrodynamic focusing. At age 31-years hematocrit (HCT) was measured by the sum of RBC counted in a specified volume of diluted blood and at age 46-years HCT were determined applying the RBC pulse-height detection.
Serum lipids
Serum cholesterol (total, HDL and LDL) and triglycerides of NFBC1966 were determined using a Hitachi 911 automatic analyser and commercial reagents (Roche, Boehringer Mannheim, Germany)
at 31-years 4, 5 and an enzymatic assay method (Advia 1800; Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA) at 46-years.
High sensitivity C-reactive protein
High sensitivity C-reactive protein (CRP) in NFBC1966 was analysed by an immunoenzymometric assay (Medix Biochemica, Espoo, Finland) at 31-years and by an immune nefelometric assay at 46-years (BN ProSpec, Siemens Healthcare Diagnostics Inc., Newark, DE, USA).
Glucose and insulin levels and fasting indices
At age 31-years fasting plasma glucose and serum insulin levels of NFBC1966 were determined by glucose dehydrogenase method (Granutest 250, Diagnostica Merck, Darmstadt, Germany) and by radioimmunoassay (Pharmacia Diagnostics, Uppsala, Sweden), respectively. At 46-years fasting plasma glucose and serum insulin levels of NFBC1966 were analysed by an enzymatic dehydrogenase method (Advia 1800, Siemens Healthcare Diagnostics, Tarrytown, NY, USA) and by a chemiluminometric immunoassay (Advia Centaur XP, Siemens Healthcare Diagnostics, Tarrytown, NY, USA), respectively.
To evaluate the insulin resistance and -cell function we calculated fasting indices HOMA-IR (fasting plasma glucose x fasting serum insulin / 22.5) and HOMA2-β ((20 x fasting serum insulin) / (fasting plasma glucose -3.5) x 100).
Oral glucose tolerance test and diabetes
A two hour oral glucose tolerance test (OGTT) was performed after overnight ( 
Serum metabolomics
Metabolic measures were obtained using the same high-throughput serum NMR metabolomics platform in the same analysis laboratory as described previously 7 . This methodology provided information on 228 serum measures, including lipoprotein subclass distribution and lipoprotein particle concentration, low molecular weight metabolites, such as amino acids, 3-hydroxybutyrate and creatinine, and detailed molecular information on serum lipids.
The metabolite data provided by this platform has been utilized in various studies in epidemiology and genetics that have been recently reviewed 8 . The method provides metabolic measures in concentration units facilitating interpretation and replication of findings.
Anthropometric measurements
Body weight and height and waist and hip circumferences of NFBC1966 participants were measured at 31-and 46-years. Body weight was measured with digital scale, which was calibrated regularly.
Height was measured twice (mean of the two measurements was used) by using standard and calibrated stadiometer. Finally, body mass index (BMI) was calculated as the ratio of weight and height squared. Waist and hip circumferences were measured twice and mean of the two measurements was used. The waist-hip ratio was assessed as the ratio between circumferences of the waist (at the level midway between lowest rib margin and the iliac crest) and the hip (at the widest trochanters). In addition, body fat mass, fat percentage, muscle mass and visceral fat area of NFBC1966 participants at 46-years were measured by InBody 720 bioelectrical impedance analyser (Biospace Co., Ltd., Seoul, Korea). All anthropometric measurements were done after overnight (12 h) fasting period. For YFS, see 3 .
Brachial blood pressure measurement
In NFBC1966 brachial systolic and diastolic blood pressure was measured two times at 31-years and three times at 46-years with 1 min interval after 15 min of rest on the right arm of the seated participants using an automated oscillometric blood pressure device and appropriately sized cuff 
Confounders and exclusions
Smoking and physical activity were used as confounders. NFBC1966 participants reported their smoking habits at 31-and 46-years and participants we categorised them as never, former and current smokers at both time points. Physical activity was inquired and categorised as inactive, moderate or high. Individuals using combined oral contraceptives, hormone replacement therapy or serum lipids lowering drugs were omitted from the metabolomics analyses, as these have been shown to greatly influence these measures (total n = 957). Individuals with known diabetes before clinical examinations were omitted from analyses. Diabetes was defined according to self-reported diagnoses and medications, hospital outpatient and inpatient registers and medication registers from Social
Insurance Institution of Finland. For YFS, see 3 .
Analyses in mice
All animal experiments were performed according to protocols approved by the Provincial State 
Statistical analyses
Regression models were used to assess the associations between Hb (main explanatory variable) and anthropometric and metabolic variables (outcome). To adjust for potential confounding factors, smoking, physical activity and sex were included as explanatory variables in the regression models.
For the analyses using YFS data, age was also included as an explanatory variable. The analyses were conducted including or excluding observations with an absolute value more than 3 standard deviations off from the mean of Hb or the (potentially transformed) outcome variable. Linear associations were assumed for all continuous variables. To ease the comparison of magnitudes of association across outcomes, the effect size estimates are reported in standard deviation units. To account for multiple comparisons in the anthropometric and metabolome-wide analyses, principal component analysis was used to estimate the number of independent tests for a Bonferroni-style multiple testing correction.
As 23 principal components explained 95% of the variation in the anthropometric and metabolic outcomes, a P value of 0.002 (0.05/23) was used as a nominal threshold for significance in these analyses. R 3.3.2 software was used for all statistical analyses (R Core Team (2013): R: a language and environment for statistical computing, Vienna, Austria, http://www.R-project.org/).
Anthropometric measures
BMI was log-transformed to eliminate skewness and heteroscedasticity in model residuals. Height was included as an additional explanatory variable in the regression models, excluding the model for BMI. The analyses were first conducted separately for the 46-age year follow-up in NFBC1966 and for YFS, and then meta-analyzed for those outcomes available in both cohorts using an inversevariance weighted random-effects model. The meta-analysis effect sizes were calculated and reported in the units in which they were measured. For the NFBC1966 dataset, similar regression models were conducted for red blood cell counts (Eryt) and hematocrit (Hct) instead of Hb, to examine the association between these measures and anthropometric variables.
Metabolic parameters
Fasting insulin levels, Matsuda and HOMA indices, AUCs and trigyceride and hsCRP levels were log-transformed to ensure symmetry and homoscedasticity of model residuals. In the hsCRP variable, including zeros in the values, the transformation used was ( + 2 ⁄ ), where = ( ≠0 ),
i.e. the smallest non-zero value in the variable. The analyses were conducted for the 46-year followup data in NFBC1966 with both including and excluding BMI as an additional explanatory variable.
NMR metabolomics
In total, 150 metabolites from the NMR metabolomics panel were analyzed (Extended data Table 8 ).
Of these, 144 were measured in concentrations, and cube-root transformation was applied to these variables 9 . The rest of the variables were left untransformed, except the degree of unsaturation, which had a notably skewed distribution and thus log-transformed to ensure homoscedasticity in model residuals. The users of combined oral contraceptives, hormone replacement therapy and lipid lowering drugs (total n = 957) were omitted because their influence on these measures 10, 11 . The analyses were conducted first separately in the NFBC1966 (at 46 years) and YFS datasets, and then meta-analyzed using inverse-variance weighted random-effects models. BMI was included as an additional explanatory variable.
Longitudinal models in NFBC1966
Extended linear models using generalized least squares were used to examine the longitudinal change in association between Hb levels and the outcomes available at two time points in the NFBC1966.
Time of measurement (ages of 31 years or 46 years) was included in the model as a categorical variable, and interaction terms with time and all other variables (excluding sex and height where applicable) were included in the model to allow varying effects between cross-sectional measurements. The error terms were allowed to be correlated within each individual and heteroskedastic between the time points. These analyses were conducted using the gls() function available in the nlme package 12 . Due to the different methods used to measure hsCRP at 31 and 46 years, an inverse normal rank transformation was applied to set the values on a comparable scale. As the glucose concentrations at the NFBC1966 31-year follow-up were measured from whole blood these values were transformed to corresponding concentrations in plasma 13 for compatibility with the data at 46-year follow-up.
Cross-sectional and longitudinal analysis of Hb levels on metabolites
To analyse both cross-sectional and longitudinal effects of Hb levels on the metabolites, Hb levels were decomposed to mean Hb ( ̅̅̅̅̅ ) for each individual and variation of Hb from the individual mean ( − ̅̅̅̅̅ ) for each individual at time point (1 = 31 years, 2 = 46 years). The following model was fit for each metabolite separately:
This model allows simultaneous estimation of the cross-sectional (between-subject) effect and the longitudinal (within-subject) effect 14 , while controlling for potentially time-varying covariates , in this case BMI, smoking and physical activity. The error terms were allowed to be correlated within each individual and heteroskedastic between the time points. These analyses were conducted using the gls() function available in the nlme package 2 .
Maximal exercise test subsample in NFBC1966
Regression models of the effects of Hb levels on oxygen consumption at rest divided by height (VO2rest/h), VO2rest/h on body fat percentage and Hb levels on body fat percentage were conducted for the subset of NFBC1966 participants at 31 years who underwent a maximal exercise test with direct measurement of oxygen consumption (M901, ergospirometer, Medikro, Finland) 15 . These analyses included sex as an additional explanatory variable.
Mendelian randomization
Bidirectional Mendelian randomization (MR) was conducted to examine a potential causality of Hb levels on BMI and vice versa. In the MR approach, genetic variants predicting an observational exposure are used as proxies for the exposure. If these variants fulfil instrumental variable assumptions 16 , then association between the variants and the outcome can give evidence for causation, eliminating problems of confounding or reverse causation. Using a P value threshold of 1 × 10 −8 , 56 and 17 single nucleotide polymorphisms (SNPs) from independent genetic loci associated with BMI and Hb, respectively, were identified from European ancestry genome-wide meta-analyses for the two traits 17, 18 . All BMI-and Hb-associated SNPs were available in the Hb and BMI meta-analysis results, respectively. After harmonizing the effect alleles for each SNP, the effect estimates and their standard errors of BMI-related SNPs were extracted from the summary statistics available for Hb and vice versa. Causal effects were estimated from these summary data using both the inverse-variance weighted (IVW) method 19 and MR-Egger regression 20 . The IVW method is a weighted regression of SNP-outcome on SNP-exposure coefficients, weighted by the inverse of the squared SNP-outcome standard errors. The slope of this model is an estimate for the causal effect. The intercept is constrained at zero, implying the assumption that the genetic data predicts the outcome only through the exposure. MR-Egger regression relaxes this assumption by including an intercept term, which is an estimate for the average pleiotropic effect of a SNP on the outcome. Testing whether this intercept equals zero serves as a test for directional pleiotropy. Assuming that magnitude of the SNP-exposure associations across all variants are independent of their pleiotropic effects, the slope in MR Egger regression provides a consistent estimate of the causal effect. Sources of bias to these causal effect estimates include deviations of the SNP-exposure estimates from the true associations, use of weak instruments, and participant overlap in the meta-analysis from where the effect estimates were calculated. In order to quantify the potential bias, relative bias estimates (the reciprocals of the F parameters 21 ) were calculated for the IVW method estimates and 2 statistics 22 for the MR Egger estimates.
Polygenic risk score analyses
We conducted polygenic risk score (PRS) analyses to further examine the association between Hb, BMI and lipids. We generated PRSs for all exposure-outcome combinations using exposure GWAS results [23] [24] [25] [26] for SNP weights, optimised for each outcome in NFBC1966 at 46 years. We used PRSice software 27 for PRS calculation, using a clumping distance of 250kb and an r 2 threshold of 0.1. Ten first genetic principal components were added as covariates to account for population stratification.
PRS was calculated for a range of p-value cut-offs (from 5x10 -8 to 1 by 0.05 increments) and we report the PRS using a p-value cut-off giving the highest R 2 with the target outcome. As NFBC1966
is part of all base GWASs used for PRS calculation, we might expect some inflation in the PRS variance explained. As a sensitivity test, we tested optimising PRS using BMI GWAS results from UKBiobank (http://www.nealelab.is/blog/2017/9/11/details-and-considerations-of-the-uk-biobankgwas) on Hb in NFBC1966 at 46 years. The R 2 for the PRS using the external GWAS results was 0.35 % (positive association, p = 4e-4), compared to 0.17 % (positive association, p = 0.01) with GWAS results with NFBC1966 included, showing no evidence for inflation in the variance explained.
Gene Set Enrichment Analysis
To examine the hypothesized activation of hypoxia response pathway, a Gene Set Enrichment Analysis (GSEA) 28 was conducted for the subset of YFS participants at 34-49 years with Hb levels and whole-blood genome-wide expression profiling data (n = 1636) 29 . The tested hypoxia response pathway included 22 genes induced at least four-fold by hypoxia in human monocytes (Extended data 
